Pharming (NASDAQ:PHAR) Stock, Quote.Headers.trade-ideas

Pharming

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

PHAR

Biotech

News

Health Care

Movers

Trading Ideas

General

Pharming&#39;s Phase 3 trial results for leniolisib in children with APDS demonstrate efficacy and safety, supporting future regulatory filings in 2025.

European Biotech Pharming Group Touts Positive Data From Pivotal Pediatric Study Of FDA-Approved Immune System Disorder Drug

movers image

Intraday Update

Markets

ACDC

ARRY

CMPS

CRMD

ENPH

GLPG

GTLS

GYRE

LUNR

PRTC

RCKT

XPEV

Galapagos, XPeng, CorMedix And Other Big Stocks Moving Higher On Monday

Headquarters_Rahway-Site-Entrance_HI

AMKR

ATPC

BIMI

BLMZ

CALC

CLDX

CNSP

CRWD

CVLT

EKSO

ENVB

FFIV

HAYW

HLIT

IMNN

INVO

ISPO

JBLU

JTAI

LSCC

LUMN

MBIN

NIPG

NVAX

ONEW

PCSA

PYPL

RGEN

RMBS

SMRT

TLRY

TRNS

TWOU

VBIV

VRNS

VSEE

Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

Pharming Group N.V. - ADS, each representing 10 ordinary shares

Pharming Group

PHARMARON BEIJING U/ADR by PHARMARON BEIJING CO LTD.

PHARNEXT by Pharnext

PHarol SGPS SA

PharmChem Inc

PHARMA FOODS INTL CO by Pharma Foods International Co., Ltd.

Pharma Foods International Co Ltd

Pharma Mar SA

PHARM-BIO SERV INC by Pharma-Bio Serv, Inc.

Pharma-Bio Serv Inc

PharmaCielo Ltd

PHARMACOM BIOVET INC by PharmaCom BioVet, Inc.

PharmaCom BioVet Inc

PharmaCyte Biotech Inc

PHARMAROTH LABS INC by PharmaRoth Labs, Inc.

PharmaRoth Labs Inc

PHARMATHER HLDGS LTD by PharmaTher Holdings Ltd.

PharmaTher Holdings Ltd

Pharmadrug Inc

Pharmagen Inc

PHARMAGREEN BIOTECH INC by Pharmagreen Biotech Inc.

Pharmagreen Biotech Inc

Pharmala Biotech Holdings Inc

PHARMALA BIOTECH HLDG INC by PharmAla Biotech Holdings Inc.

PHARMARON BEIJING CO LTD by PHARMARON BEIJING CO LTD.

Pharmaron Beijing Co Ltd

PHARMING GROUP NV ORD by Pharming Group NV

Pharnext SA

Pharos Energy PLC

Pharvaris NV

Oppenheimer analyst Jeff Jones maintained a Buy rating on Pharming Group (PHAR – Research Report) today and set a price target of $31.00. The compa...

Oppenheimer Sticks to Its Buy Rating for Pharming Group (PHAR)

H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Pharming Group (PHAR – Research Report) today and set a price target of $37.00....

Buy Rating Affirmed for Pharming Group on Leniolisib's Progress and Joenja's Market Expansion

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Pharming Group (PHAR – Research Report) and MoonLake...

Analysts Offer Insights on Healthcare Companies: Pharming Group (PHAR) and MoonLake Immunotherapeutics (MLTX)

Pharming reports Q3 results

In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Pharming Group (PHAR – Research Report), with a price ...

Positive Outlook for Pharming Group Amidst Growth Opportunities and Leadership Transition

Pharming Group N.V. (PHAR) Q3 2024 Earnings Call Transcript

Oppenheimer analyst Jeff Jones lowered the firm's price target on Pharming (PHAR) to $30 from $31 and keeps an Outperform rating on the shares foll...

Pharming price target lowered to $30 from $31 at Oppenheimer

RBC Capital lowered the firm's price target on Pharming (PHAR) to EUR 1.60 from EUR 1.65 and keeps an Outperform rating on the shares. Published fi...

Pharming price target lowered to EUR 1.60 from EUR 1.65 at RBC Capital

Jefferies initiated coverage of Pharming (PHAR) with a Buy rating and $14 price target The firm believes the market is either underappreciating the...

Pharming initiated with a Buy at Jefferies

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Pharming Group (PHAR – Research Report) and GE Healt...

Analysts Offer Insights on Healthcare Companies: Pharming Group (PHAR) and GE Healthcare Technologies Inc (GEHC)

GEHC

MLTX

PHGUF

Press Releases

Pharming Group to participate in June investor conferences

Pharming Group to report second quarter and first half 2024 financial results on August 1

Earnings

Pharming Group reports second quarter and first half 2024 financial results and provides business update

Pharming Group to participate in September investor conferences

Pharming announces marketing authorization in the U.K. for Joenja® (leniolisib)

Pharming Group announces start of Phase II clinical trial of leniolisib for primary immunodeficiencies (PIDs) with immune dysregulation

Pharming Group to report third quarter 2024 financial results on October 24

Pharming Group reports third quarter 2024 financial results and provides business update

Pharming Group to participate in November investor conference

Pharming announces positive topline data in pediatric clinical trial of leniolisib

Altimmune

Astria Therapeutics

Anavex Life Sciences Corp. - Common Stock

Anavex Life Sciences

Capricor Therapeutics, Inc. - Common Stock

Capricor Therapeutics

Cullinan Therapeutics, Inc. - Common Stock

Cullinan Therapeutics

Cargo Therapeutics

Dianthus Therapeutics, Inc. - Common Stock

Dianthus Therapeutics

GRAIL

Humacyte

IGM Biosciences

Ironwood Pharmaceuticals, Inc. - Class A Common Stock

Ironwood Pharmaceuticals

Mineralys Therapeutics, Inc. - Common Stock

Mineralys Therapeutics

Mereo BioPharma Group plc - American Depositary Shares

Mereo BioPharma Group

Olema Pharmaceuticals, Inc. - Common Stock

Olema Pharmaceuticals

Opthea Limited - American Depositary Shares

Opthea

Oric Pharmaceuticals, Inc. - Common Stock

ORIC Pharmaceuticals

Prothena Corporation plc - Ordinary Shares

Prothena Corp

PureTech Health plc - American Depositary Shares

PureTech Health

Cartesian Therapeutics, Inc. - Common Stock

Cartesian Therapeutics

Stoke Therapeutics

Savara

Tectonic Therapeutic, Inc. - Common Stock

Tectonic Therapeutic

Entrada Therapeutics, Inc. - Common Stock

Comments

Pharming

Pharming (PHAR) Forecast

Pharming (NASDAQ:PHAR) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga